Last month, we had the opportunity to attend the DIA Global Annual Meeting, a major event for the pharmaceutical and biotech sectors. With professionals from four different continents, DIA 2024 provided an excellent venue to collaborate, advance ideas, and shape the future of clinical operations. At Artyc, our goal is making a contribution to these efforts through modernizing the cold chain and improving temperature-controlled shipping. From winning an award to engaging in enriching discussions, these were our top 3 highlights from the event.
Our Medstow Micro was honored as the Best in Show New Product Competition Winner at DIA 2024. We were incredibly humbled by this distinction, as it underscores the impact of our work on temperature-controlled transportation. We’re deeply grateful to the DIA for this recognition, and are excited to continue developing solutions for a more sustainable, resilient and equitable cold chain.
Throughout the conference, a recurring theme was the significant growth potential of direct-to-patient (DTP) and direct-from-patient (DFP) shipping. Echoing sentiments from the BIO 2024 conference, industry experts emphasized the increasing importance of DTP solutions for improving patient access to new products and clinical trials. More than anything, this shift is driven by the demand for better access to healthcare solutions and the efficiency of patient-centric logistics. Throughout the industry, major players are actively seeking partnerships and acquisitions to integrate these solutions, reflecting a broader trend toward patient-focused innovation.
Engaging with sponsors, sites, pharma services, and professionals provided us with valuable feedback on our track and trace capabilities. Notably, the addition of cellular tracking to the Medstow Micro was well-received. This enhancement aligns with mandates from both the EPA and FDA, which were highlighted at DIA 2024, and that emphasize the importance of public health and data monitoring. Collectively, these discussions reinforced our commitment to providing robust, data-driven solutions that safeguard the integrity of medical products throughout their journey.
Participating in DIA 2024 was an incredible opportunity for Artyc. We connected with industry leaders, presented our solutions, and gained deep insights into the future of the biotech and pharmaceutical sectors. From the enthusiasm surrounding our Medstow Micro and the focus on direct-to-patient logistics to the positive reception of our track and trace features, we couldn’t have been more grateful for the response.
We’re excited to continue these conversations, and to keep advancing the future of temperature-controlled transportation together.
Get in touch and let's make a difference together.
Contact UsArtyc™ All Rights Reserved, 2024.